Questioning the Associations of ω-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks-Reply

Affiliations

Comment

Robert J Clarke et al. JAMA Cardiol. 2018.

. 2018 Aug 1;3(8):781-782.

doi: 10.1001/jamacardio.2018.1312.

¹ Clinical Trial Service Unit, Nuffield Department of Population Health, University of Oxford, Oxford, England.

No abstract available

Comment on

Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals.
Aung T, Halsey J, Kromhout D, Gerstein HC, Marchioli R, Tavazzi L, Geleijnse JM, Rauch B, Ness A, Galan P, Chew EY, Bosch J, Collins R, Lewington S, Armitage J, Clarke R; Omega-3 Treatment Trialists’ Collaboration. Aung T, et al. JAMA Cardiol. 2018 Mar 1;3(3):225-234. doi: 10.1001/jamacardio.2017.5205. JAMA Cardiol. 2018. PMID: 29387889 Free PMC article.
Questioning the Associations of ω-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks.
Nodari S, Butler J, Temporelli PL. Nodari S, et al. JAMA Cardiol. 2018 Aug 1;3(8):781. doi: 10.1001/jamacardio.2018.1309. JAMA Cardiol. 2018. PMID: 29874369 No abstract available.
Questioning the Associations of ω-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks.
Cicero AFG, Fogacci F, Borghi C. Cicero AFG, et al. JAMA Cardiol. 2018 Aug 1;3(8):780-781. doi: 10.1001/jamacardio.2018.1306. JAMA Cardiol. 2018. PMID: 29874376 No abstract available.